Avilex Pharma develops novel inhibitors of PDZ domain proteins to target a range of unmet medical needs with a lead drug candidate AVLX-144 for the treatment of ischemic stroke.
If you can't find it here or have feedback to our website, please do not hesitate to contact firstname.lastname@example.org or 28895854
Copyright 2015 Danskbiotek. All rights reserved.
created by: Mastafu Design